Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2014


European Statistical Forum 2014

17 Nov 2014 - 17 Nov 2014 - Brussels, Belgium



Bookmark and Share


The EUROPEAN STATISTICAL FORUM is pleased to announce its 5th Annual Conference:

The current status of the application of Bayesian Methods in Drug Development

In the last years the biostatistics community has increased its interest in the application of Bayesian methodology in drug development as it provides a framework for determining probabilities relevant to inferences from current trials and previous knowledge.

Bayesian statistics has the potential to play an important role throughout the drug/device development process lifecycle and in particular in the decision-making process. Its range of applications contains early phase studies, dose-finding, safety analyses, meta-analyses, decision theory as well as the quantification of the benefits and risks essential to health economic evaluation. While the use of Bayesian methodologies has significantly increased in the recent years in exploratory clinical trials, its use in confirmatory clinical trials is still not common.

The fifth edition of the European Statistical Forum is dedicated to Bayesian Statistics, in particular by presenting:

  •  Current state-of-art implementation in clinical trials
  •  Recent enhancements in the methodology
  •  Regulatory perspectives on its application in clinical trials.

The conference aims at promoting the exchange of expertise in the field coming from academia and industry as well as regulators.

The Scientific Board:

  • Jens-Otto Andreas, Director, Head Global Biostatistics EU Group, UCB BIOSCIENCES GmbH
  • Lisa Comarella, Director, Biostatistics, Senior Project Manager, Cros NT Group
  • Frank Fleischer, Global BCA, Boehringer Ingelheim Pharma GmbH & Co. KG
  • Giacomo Mordenti, Senior Director Compound Development & Branding-Head Biostatistics, Grünenthal 

will share best practices, results and experiences in this field.

Who should attend?

The conference is addressed to Statisticians and Professionals with a deep interest in the application of Bayesian methodology in clinical trials belonging to: Pharmaceutical, Biotechnology and related Industries, CROs, Academy, Hospital Centres, University.

Pre-Conference Dinner at Aux Armes de Bruxelles, Brussels

Sunday, 16th November, 7:30 pm

For further information, please visit: www.esforum.eu




Further information
Scientific News
Advancing Synthetic Biology
Living systems rely on a dizzying variety of chemical reactions essential to development and survival. Most of these involve a specialized class of protein molecules — the enzymes.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Honey’s Potential to Save Lives
The healing powers of honey have been known for thousands of years.
Muscles on-a-Chip
This study may help explain why stem cell-based therapies have so far shown limited benefits for heart attack patients in clinical trials.
3-D Printed Lifelike Liver Tissue for Drug Screening
A team led by engineers at the University of California, San Diego has 3D-printed a tissue that closely mimics the human liver's sophisticated structure and function. The new model could be used for patient-specific drug screening and disease modeling.
Envigo Rat Models Proven to be Susceptible to Intra-Vaginal HSV-2 Infection and Protectable
Scientific findings establish the effectiveness of new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection.
Valvena, GSK Sign New R&D Collaboration
Valneva to supply process development services for EB66® -based Influenza vaccines.
Food Triggers Creation of Regulatory T Cells
IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!